Sigvotatug Antibody
Sigvotatug Vedotin is an antibody-drug conjugate (ADC) targeting integrin αvβ6-positive tumors. Its protease-cleavable linker delivers the microtubule inhibitor MMAE into cells, causing cytotoxic disruption of cell division. This ADC is a research tool for studying targeted oncology in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
SGN-B6A antibody
Target
Integrin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
7.56 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.46 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
